
How we assess the commercialisation prospects of medical devices
CurveBeam AI: A case study Rory Hunter, Portfolio Manager for the SGH Emerging Companies Fund and the SGH Medical Technology...
Read more
Reporting Season Wrap: Praemium – the emerging opportunity
By Rory Hunter Fintech platform Praemium (ASX:PPS) released their FY23 full year result during August, which we highlight as the...
Read more
Artificial Intelligence and the Opportunity in Healthcare
By Rory Hunter, Portfolio Manager of the SGH Medical Technology Fund and the SGH Opportunities Fund Ripe for disruption. The US...
Read more
SGH Property Income Fund is a Finalist at a Fund Manager of the Year Awards
SG Hiscock are pleased to announce that SGH Property Income fund has been recognised as a finalist for the 35th...
Read more
Emerging Companies Insights: US macroeconomic developments
By Rory Hunter It is intriguing to look back at our previous insights publications with the benefit of more recent macro...
Read more
SGH Insights: US regional banking crisis and what it means for investment opportunities
By Rory Hunter, 30 March 2023 As my colleague, Hamish Tadgell, recently noted in his piece “Crisis of Confidence”, in...
Read more
Investment Insights: Crisis of Confidence
“The Depression, which started in 1929 was rather mild from 1929 to 1930. And, indeed, in my opinion would have...
Read more